Rifaximin: a review of its use in reducing recurrence of overt hepatic encephalopathy episodes.
about
Early to Phase II drugs currently under investigation for the treatment of liver fibrosis.Palliative care for patients with end-stage liver disease.Rifamycins, Alone and in Combination.Second prophylaxis of variceal bleeding in cirrhotic patients with a high HVPG.Design of the Prospective Real-world Outcomes Study of hepatic encephalopathy Patients' Experience on Rifaximin-α (PROSPER): an observational study among 550 patients
P2860
Rifaximin: a review of its use in reducing recurrence of overt hepatic encephalopathy episodes.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Rifaximin: a review of its use ...... patic encephalopathy episodes.
@ast
Rifaximin: a review of its use ...... patic encephalopathy episodes.
@en
type
label
Rifaximin: a review of its use ...... patic encephalopathy episodes.
@ast
Rifaximin: a review of its use ...... patic encephalopathy episodes.
@en
prefLabel
Rifaximin: a review of its use ...... patic encephalopathy episodes.
@ast
Rifaximin: a review of its use ...... patic encephalopathy episodes.
@en
P2860
P1433
P1476
Rifaximin: a review of its use ...... patic encephalopathy episodes.
@en
P2860
P2888
P304
P356
10.1007/S40265-014-0300-Y
P577
2014-12-01T00:00:00Z